Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism
Open accessThe DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Oxygen deprivation or hypoxia characterizes a number of serious pathological conditions and elicits a number of adaptive changes that are mainly mediated at the transcriptional level by the family of hypoxia-inducible factors (HIFs). The HIF target gene repertoire includes genes responsible for the regulation of metabolism, oxygen delivery and cell survival. Although the involvement of HIFs in the regulation of carbohydrate metabolism and the switch to anaerobic glycolysis under hypoxia is well established, their role in the control of lipid anabolism and catabolism remains still relatively obscure. Recent evidence indicates that many aspects of lipid metabolism are modified during hypoxia or in tumor cells in a HIF-dependent manner, contributing significantly to the pathogenesis and/or progression of cancer and metabolic disorders. However, direct transcriptional regulation by HIFs has been only demonstrated in relatively few cases, leaving open the exact and isoform-specific mechanisms that underlie HIF-dependency. This review summarizes the evidence for both direct and indirect roles of HIFs in the regulation of genes involved in lipid metabolism as well as the involvement of HIFs in various diseases as demonstrated by studies with transgenic animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF-1α also promotes the activation of the mitochondrial IDH2 isoform, which promotes the reductive carboxylation of glutamine-derived α-KG to drive the reverse TCA cycle [62].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [62]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328 · cited 1×
“To also maintain de novo FA synthesis under hypoxia, production of FA precursors is supported in human renal cell carcinoma (RCC) as well as other cancer cells through HIF-dependent stimulation of reductive glutamine metabolism [53,54].”
BackgroundOxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
The interaction of hepatic lipid and glucose metabolism in liver diseases
Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M., & Canbay, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.025 · Cited by 994
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975 · cited 1×
“It has to be pointed out that, in many cancer types, silencing of HIFs or interfering with the expression of its target genes required for lipid accumulation, results in reduction of proliferation potential and chemoresistance under hypoxia [49,55,57,59,62,63,65,68,70,78,79].”
BackgroundSirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758 · cited 1×
“Post-translationally, in addition to hydroxylation, HIF-1α is subject to SUMOylation [17–20], acetylation [21,22], deacetylation [23] and S-nitrosylation [24], although the impact of these modifications on HIF-1α stability and/or activity has not yet been adequately clarified.”
BackgroundRegulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Kallio, P. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6573 · Cited by 666
Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J.-L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.056 · Cited by 665
SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia
Cheng, J., Kang, X., Zhang, S., & Yeh, E. T. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.045 · Cited by 624
Lee, Y. S., Kim, J.-W., Osborne, O., Oh, D. Y., Sasik, R., Schenk, S., Chen, A., Chung, H., Murphy, A., Watkins, S. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.012 · Cited by 598
Liu, Y. V., Baek, J. H., Zhang, H., Diez, R., Cole, R. N., & Semenza, G. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.001 · Cited by 478
Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1
Dioum, E. M., Chen, R., Alexander, M. S., Zhang, Q., Hogg, R. T., Gerard, R. D., & Garcia, J. A. (2009) · Science · doi:10.1126/science.1169956 · Cited by 472
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Du, W., Zhang, L., Brett-Morris, A., Aguila, B., Kerner, J., Hoppel, C. L., Puchowicz, M., Serra, D., Herrero, L., Rini, B. I., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01965-8 · Cited by 468
Inhibition of PPARγ2 Gene Expression by the HIF-1-Regulated Gene DEC1/Stra13
Yun, Z., Maecker, H. L., Johnson, R. S., & Giaccia, A. J. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00131-4 · Cited by 458
Regulation of HIF-1α Stability through S-Nitrosylation
Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.024 · Cited by 437
BelAiba, R. S., Bonello, S., Zähringer, C., Schmidt, S., Hess, J., Kietzmann, T., & Görlach, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0391 · Cited by 423
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 407
Krishnan, J., Suter, M., Windak, R., Krebs, T., Felley, A., Montessuit, C., Tokarska-Schlattner, M., Aasum, E., Bogdanova, A., Perriard, E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.05.005 · Cited by 404
Qiu, B., Ackerman, D., Sanchez, D. J., Li, B., Ochocki, J. D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., & Simon, M. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1507 · Cited by 394
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
Lipid Droplets in Cancer: Guardians of Fat in a Stressful World
Petan, T., Jarc, E., & Jusović, M. (2018) · Molecules · doi:10.3390/molecules23081941 · Cited by 368
Huang, D., Li, T., Li, X., Zhang, L., Sun, L., He, X., Zhong, X., Jia, D., Song, L., Semenza, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.028 · Cited by 352 · cited 4×
“LCAD HIF-1 Negative Reduced expression HIF-1α depletion inhibits reduction of LCAD expression under hypoxia [71]”
BackgroundInfluentialSun, R. C., & Denko, N. C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.022 · Cited by 344 · cited 4×
“Moreover, HIF-1 increases the amount of α-ketoglutarate, which can be used as substrate for citrate synthesis and FA/lipid production, by inducing the expression of GLS1 (glutaminase 1) [58], as well as, by inducing the E3 ubiquitin ligase SIAH2, which in turn mediates the proteolysis of the E1 subunit (OGDH2) of the…”
BackgroundInfluentialSignalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 341
Hypoxia-inducible factor 2 regulates hepatic lipid metabolism
Rankin, E. B., Rha, J., Selak, M. A., Unger, T. L., Keith, B., Liu, Q., & Haase, V. H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00200-09 · Cited by 338
Gameiro, P. A., Yang, J., Metelo, A. M., Pérez-Carro, R., Baker, R., Wang, Z., Arreola, A., Rathmell, W. K., Olumi, A., López-Larrubia, P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.002 · Cited by 325 · cited 2×
“To also maintain de novo FA synthesis under hypoxia, production of FA precursors is supported in human renal cell carcinoma (RCC) as well as other cancer cells through HIF-dependent stimulation of reductive glutamine metabolism [53,54].”
BackgroundCarbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G. K., Holsboer, F., & Arzt, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.044 · Cited by 318
Krishnan, J., Danzer, C., Simka, T., Ukropec, J., Walter, K. M., Kumpf, S., Mirtschink, P., Ukropcova, B., Gasperikova, D., Pedrazzini, T., et al. (2012) · Genes & Development · doi:10.1101/gad.180406.111 · Cited by 314
Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation
Ackerman, D., Tumanov, S., Qiu, B., Michalopoulou, E., Spata, M., Azzam, A., Xie, H., Simon, M. C., & Kamphorst, J. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.015 · Cited by 305
Pharmacologic Targeting of Hypoxia-Inducible Factors
Semenza, G. L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021637 · Cited by 288 · cited 1×
“A number of HIF inhibitors are currently being tested, along with conventional therapies, for the treatment of different types of cancer [116], as cancer cells depend on HIF function, including HIF-mediated stimulation of lipid synthesis, for survival, proliferation and metastasis.”
BackgroundNegative and positive regulation of HIF-1: A complex network
Bárdos, J. I., & Ashcroft, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 285
HIF and the Lung: Role of Hypoxia-inducible Factors in Pulmonary Development and Disease
Shimoda, L. A., & Semenza, G. L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1393pp · Cited by 277
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
Ivan, M., & Kaelin, W. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.002 · Cited by 273 · cited 1×
“or partners [108], pulmonary hypertension has been long known to be linked to HIF activation, since exposure to chronic hypoxia can indeed cause pulmonary arterial smooth muscle cell proliferation, migration and hypertrophy leading to pulmonary vascular remodeling and eventually pulmonary hypertension [109].”
BackgroundHypoxia-inducible factor 3 biology: complexities and emerging themes
Duan, C. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00315.2015 · Cited by 269
The Metabolic Basis of Pulmonary Arterial Hypertension
Sutendra, G., & Michelakis, E. D. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.004 · Cited by 268
Jiang, C., Qu, A., Matsubara, T., Chanturiya, T., Jou, W., Gavrilova, O., Shah, Y. M., & Gonzalez, F. J. (2011) · Diabetes · doi:10.2337/db11-0174 · Cited by 268
Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., & Simos, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605058200 · Cited by 266
Self-citationmTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
Flügel, D., Görlach, A., Michiels, C., & Kietzmann, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00015-07 · Cited by 258
The Asparaginyl Hydroxylase Factor Inhibiting HIF-1α Is an Essential Regulator of Metabolism
Zhang, N., Fu, Z., Linke, S., Chicher, J., Gorman, J. J., Visk, D., Haddad, G. G., Poellinger, L., Peet, D. J., Powell, F., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.001 · Cited by 246
Sutendra, G., Bonnet, S., Rochefort, G., Haromy, A., Folmes, K. D., Lopaschuk, G. D., Dyck, J. R. B., & Michelakis, E. D. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001327 · Cited by 245
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235
Sumoylation increases HIF-1α stability and its transcriptional activity
Bae, S.-H., Jeong, J.-W., Park, J. A., Kim, S.-H., Bae, M.-K., Choi, S.-J., & Kim, K.-W. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.068 · Cited by 232
Dai, Z., Li, M., Wharton, J., Zhu, M. M., & Zhao, Y.-Y. (2016) · Circulation · doi:10.1161/circulationaha.116.021494 · Cited by 232
Selective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction
Sun, K., Halberg, N., Khan, M., Magalang, U. J., & Scherer, P. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00951-12 · Cited by 231 · cited 1×
“Adipocyte specific KO of HIF1A [82,91–93], inhibition of HIF-1 by acriflavine [91] or PX-478 [94], or adipocyte specific ARNT KO [93,95] decreased obesity and insulin resistance in mice fed with high-fat diet.”
BackgroundXiang, L., Mou, J., Shao, B., Wei, Y., Liang, H., Takano, N., Semenza, G. L., & Xie, G. (2019) · Cell Death & Disease · doi:10.1038/s41419-018-1291-5 · Cited by 223 · cited 2×
“Moreover, HIF-1 increases the amount of α-ketoglutarate, which can be used as substrate for citrate synthesis and FA/lipid production, by inducing the expression of GLS1 (glutaminase 1) [58], as well as, by inducing the E3 ubiquitin ligase SIAH2, which in turn mediates the proteolysis of the E1 subunit (OGDH2) of the…”
BackgroundYoung, R. M., Ackerman, D., Quinn, Z. L., Mancuso, A., Gruber, M., Liu, L., Giannoukos, D. N., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., et al. (2013) · Genes & Development · doi:10.1101/gad.198630.112 · Cited by 215
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
Poon, E., Harris, A. L., & Ashcroft, M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 213
Oxygen availability and metabolic reprogramming in cancer
Xie, H., & Simon, M. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.799973 · Cited by 206
Nath, B., Levin, I., Csak, T., Petrasek, J., Mueller, C., Kodys, K., Catalano, D., Mandrekar, P., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24256 · Cited by 190
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.002 · Cited by 190
New horizons in hypoxia signaling pathways
Pugh, C. W., & Ratcliffe, P. J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.008 · Cited by 184
Qu, A., Taylor, M., Xue, X., Matsubara, T., Metzger, D., Chambon, P., Gonzalez, F. J., & Shah, Y. M. (2011) · Hepatology · doi:10.1002/hep.24400 · Cited by 181
Hypoxia Converts Human Macrophages Into Triglyceride-Loaded Foam Cells
Boström, P., Magnusson, B., Svensson, P.-A., Wiklund, O., Borén, J., Carlsson, L. M. S., Ståhlman, M., Olofsson, S.-O., & Hultén, L. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000229665.78997.0b · Cited by 176
Kietzmann, T., Mennerich, D., & Dimova, E. Y. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00011 · Cited by 176
Gimm, T., Wiese, M., Teschemacher, B., Deggerich, A., Schödel, J., Knaup, K. X., Hackenbeck, T., Hellerbrand, C., Amann, K., Wiesener, M. S., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-159806 · Cited by 174
Depping, R., Steinhoff, A., Schindler, S., Friedrich, B., Fagerlund, R., Metzen, E., Hartmann, E., & Köhler, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.12.006 · Cited by 170
Perman, J. C., Boström, P., Lindbom, M., Lidberg, U., StÅhlman, M., Hägg, D., Lindskog, H., Scharin Täng, M., Omerovic, E., Mattsson Hultén, L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43068 · Cited by 168
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis
Xie, C., Yagai, T., Luo, Y., Liang, X., Chen, T., Wang, Q., Sun, D., Zhao, J., Ramakrishnan, S. K., Sun, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4412 · Cited by 161
Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia
Zhang, X., Saarinen, A. M., Hitosugi, T., Wang, Z., Wang, L., Ho, T. H., & Liu, J. (2017) · eLife · doi:10.7554/elife.31132 · Cited by 150
Lei, L., Mason, S., Liu, D., Huang, Y., Marks, C., Hickey, R., Jovin, I. S., Pypaert, M., Johnson, R. S., & Giordano, F. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01580-07 · Cited by 147
How lipid droplets “TAG” along: Glycerolipid synthetic enzymes and lipid storage
Wang, H., Airola, M. V., & Reue, K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.06.010 · Cited by 145
Hypoxia causes triglyceride accumulation via HIF-1-mediated stimulation of lipin 1 expression
Mylonis, I., Sembongi, H., Befani, C., Liakos, P., Siniossoglou, S., & Simos, G. (2012) · Journal of Cell Science · doi:10.1242/jcs.106682 · Cited by 137
Self-citationSUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity
Berta, M., Mazure, N. M., Hattab, M., Pouysségur, J., & Brahimi-Horn, M. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.103 · Cited by 135
HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice
Nishiyama, Y., Goda, N., Kanai, M., Niwa, D., Osanai, K., Yamamoto, Y., Senoo‐Matsuda, N., Johnson, R. S., Miura, S., Kabe, Y., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.024 · Cited by 131
Liu, Y., Ma, Z., Zhao, C., Wang, Y., Wu, G., Xiao, J., McClain, C. J., Li, X., & Feng, W. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.033 · Cited by 126
Zhang, X., Lam, K. S. L., Ye, H., Chung, S. K., Zhou, M., Wang, Y., & Xu, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135509 · Cited by 112
Bullen, J. W., Tchernyshyov, I., Holewinski, R. J., DeVine, L., Wu, F., Venkatraman, V., Kass, D. L., Cole, R. N., Van Eyk, J., & Semenza, G. L. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0583 · Cited by 109
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming
D'Alessandro, A., El Kasmi, K. C., Plecitá-Hlavatá, L., Ježek, P., Li, M., Zhang, H., Gupte, S. A., & Stenmark, K. R. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7217 · Cited by 109
CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth
Warfel, N. A., Dolloff, N. G., Dicker, D. T., Malysz, J., & El-Deiry, W. S. (2013) · Cell Cycle · doi:10.4161/cc.26930 · Cited by 108
Luo, J. C., & Shibuya, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204228 · Cited by 107
Transport of hypoxia-inducible factor HIF-1α into the nucleus involves importins 4 and 7
Chachami, G., Paraskeva, E., Mingot, J. M., Braliou, G. G., Görlich, D., & Simos, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.093 · Cited by 104
Self-citationSiniossoglou, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.014 · Cited by 101
Xu, D., Yao, Y., Lu, L., Costa, M., & Dai, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160325 · Cited by 100
Ravenna, L., Salvatori, L., & Russo, M. A. (2016) · The FEBS Journal · doi:10.1111/febs.13572 · Cited by 97
Mylonis, I., Chachami, G., Paraskeva, E., & Simos, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803081200 · Cited by 96
Self-citationHIF and pulmonary vascular responses to hypoxia
Shimoda, L. A., & Laurie, S. S. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00643.2013 · Cited by 95
Lee, K. Y., Gesta, S., Boucher, J., Wang, X. L., & Kahn, C. R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.006 · Cited by 92
Rahtu-Korpela, L., Määttä, J., Dimova, E. Y., Hörkkö, S., Gylling, H., Walkinshaw, G., Hakkola, J., Kivirikko, K. I., Myllyharju, J., Serpi, R., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307136 · Cited by 90
Casein kinase 1 regulates human hypoxia-inducible factor HIF-1
Kalousi, A., Mylonis, I., Politou, A. S., Chachami, G., Paraskeva, E., & Simos, G. (2010) · Journal of Cell Science · doi:10.1242/jcs.068122 · Cited by 88
Self-citationMylonis, I., Kourti, M., Samiotaki, M., Panayotou, G., & Simos, G. (2017) · Journal of Cell Science · doi:10.1242/jcs.195339 · Cited by 80
Self-citationHypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
Valli, A., Rodriguez, M., Moutsianas, L., Fischer, R., Fedele, V., Huang, H.-L., Van Stiphout, R., Jones, D., Mccarthy, M., Vinaxia, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3058 · Cited by 79
Castellano, J., Aledo, R., Sendra, J., Costales, P., Juan-Babot, O., Badimon, L., & Llorente-Cortés, V. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.225490 · Cited by 79
Matsuura, H., Ichiki, T., Inoue, E., Nomura, M., Miyazaki, R., Hashimoto, T., Ikeda, J., Takayanagi, R., Fong, G.-H., & Sunagawa, K. (2013) · Circulation · doi:10.1161/circulationaha.113.001742 · Cited by 77
SEPT9_v1 Up-regulates Hypoxia-inducible Factor 1 by Preventing Its RACK1-mediated Degradation
Amir, S., Wang, R., Simons, J. W., & Mabjeesh, N. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808348200 · Cited by 76
Hu, B., Guo, Y., Garbacz, W. G., Jiang, M., Xu, M., Huang, H., Tsung, A., Billiar, T. R., Ramakrishnan, S. K., Shah, Y. M., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.030 · Cited by 76
Maier, A., Wu, H., Cordasic, N., Oefner, P. J., Dietel, B., Thiele, C., Weidemann, A., Eckardt, K., & Warnecke, C. (2017) · The FASEB Journal · doi:10.1096/fj.201700235r · Cited by 76
Jiang, C., Kim, J.-H., Li, F., Qu, A., Gavrilova, O., Shah, Y. M., & Gonzalez, F. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426338 · Cited by 74
Triantafyllou, E.-A., Georgatsou, E., Mylonis, I., Simos, G., & Paraskeva, E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.015 · Cited by 71
Self-citationBaek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Zhang, H., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705627200 · Cited by 70
Zhang, L., Li, L., Liu, H. H., Prabhakaran, K., Zhang, X., Borowitz, J. L., & Isom, G. E. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.005 · Cited by 68
Vlaminck, B., Toffoli, S., Ghislain, B., Demazy, C., Raes, M., & Michiels, C. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06072.x · Cited by 61 · cited 1×
“Transcription of HIF1A also involves STAT3 (signal transducer and activator of transcription 3) [12] and Sp1 [13].”
BackgroundAdipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
Michailidou, Z., Morton, N. M., Moreno Navarrete, J. M., West, C. C., Stewart, K. J., Fernández-Real, J. M., Schofield, C. J., Seckl, J. R., & Ratcliffe, P. J. (2015) · Diabetes · doi:10.2337/db14-0233 · Cited by 60
Karagiota, A., Kourti, M., Simos, G., & Mylonis, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2985-7 · Cited by 59
Self-citationArai, T., Tanaka, M., & Goda, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-32586-w · Cited by 53
Activation of Hypoxia‐Inducible Factor‐2 in Adipocytes Results in Pathological Cardiac Hypertrophy
Lin, Q., Huang, Y., Booth, C. J., Haase, V. H., Johnson, R. S., Simon, M. C., Giordano, F. J., & Yun, Z. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000548 · Cited by 52
Marsch, E., Demandt, J. A. F., Theelen, T. L., Tullemans, B. M. E., Wouters, K., Boon, M. R., van Dijk, T. H., Gijbels, M. J., Dubois, L. J., Meex, S. J. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw156 · Cited by 52
Schleicher, J., Guthke, R., Dahmen, U., Dirsch, O., Holzhütter, H., & Schuster, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.016 · Cited by 50
HIF‐1α Expression as a Protective Strategy of HepG2 Cells Against Fatty Acid‐Induced Toxicity
Yoo, W., Noh, K. H., Ahn, J. H., Yu, J. H., Seo, J. A., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Kim, T. W., et al. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24757 · Cited by 47
Kourti, M., Ikonomou, G., Giakoumakis, N.-N., Rapsomaniki, M., Landegren, U. D., Siniossoglou, S., Lygerou, Z., Simos, G., & Mylonis, I. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.017 · Cited by 47
Self-citationPapadakis, A. I., Paraskeva, E., Peidis, P., Muaddi, H., Li, S., Raptis, L., Pantopoulos, K., Simos, G., & Koromilas, A. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0215 · Cited by 47
Self-citationMetabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
Izquierdo-García, J. L., Arias, T., Rojas, Y., Garcia-Ruiz, V., Santos, A., Martín-Puig, S., & Ruíz-Cabello, J. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00110 · Cited by 39
Tsapournioti, S., Mylonis, I., Hatziefthimiou, A. A., Ιωάννου, Μ., Stamatiou, R., Koukoulis, G. K., Simos, G., Molyvdas, P., & Paraskeva, E. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24331 · Cited by 37
Self-citationHIF-2α phosphorylation by CK1δ promotes erythropoietin secretion in liver cancer cells under hypoxia
Pangou, E., Befani, C., Mylonis, I., Samiotaki, M., Panayotou, G., Simos, G., & Liakos, P. (2016) · Journal of Cell Science · doi:10.1242/jcs.191395 · Cited by 37
Self-citationMgcRacGAP Interacts with HIF-1α and Regulates its Transcriptional Activity
Lyberopoulou, A., Venieris, E., Mylonis, I., Chachami, G., Pappas, I., Simos, G., Bonanou, S., & Georgatsou, E. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110460 · Cited by 36
Self-citationNovel roles of hypoxia response system in glucose metabolism and obesity
Ichiki, T., & Sunagawa, K. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.03.004 · Cited by 36
Hypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 34
Han, J. S., Lee, J. H., Kong, J., Ji, Y., Kim, J., Choe, S. S., & Kim, J. B. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00390-18 · Cited by 25
Sun, W., Kato, H., Kitajima, S., Lee, K. L., Gradin, K., Okamoto, T., & Poellinger, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-05685-3 · Cited by 16
Lyberopoulou, A., Mylonis, I., Papachristos, G., Sagris, D., Kalousi, A., Befani, C. D., Liakos, P., Simos, G., & Georgatsou, E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.025 · Cited by 15
Self-citationMetabolic Dysfunction in the Pathogenesis of Pulmonary Hypertension
Rubin, L. J. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.006 · Cited by 9
Cited by
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z.-J., Xi, M.-J., Xia, B.-H., Deng, K., & Yang, J.-L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 481
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
“Concurrently, when a reporter plasmid carrying HBV Enh1 was transfected into hepatoma cells under hypoxia, the HBV enhancer 1 (Enh1) activity was augmented.223 In hepatocarcinogenesis, HBx protein may be a critical mediator of hypoxia-induced angiogenesis.223 It increases the transcriptional and translational level an…”
BackgroundInfluentialWu, D., Chang, X., Tian, J., Kang, L., Wu, Y., Liu, J., Wu, X., Huang, Y., Gao, B., Wang, H., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00958-6 · Cited by 263
Seo, J., Jeong, D.-W., Park, J.-W., Lee, K.-W., Fukuda, J., & Chun, Y.-S. (2020) · Communications Biology · doi:10.1038/s42003-020-01367-5 · Cited by 237
Metabolism in Pulmonary Hypertension
Xu, W., Janocha, A. J., & Erzurum, S. C. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-123956 · Cited by 187
Metadata
- Authors
- Mylonis, I., Simos, G., & Paraskeva, E.
- Affiliations
- University of Thessaly (GR)
- Corresponding author
- Simos, George
- Paraskeva, Efrosyni
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-03-03
- Volume
- 8
- Issue
- 3
- Pages
- 214
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6468845
- OpenAlex
- W2919736532
- Cited by
- 316
- References
- 118
- Citations by year
- 2026: 41 · 2025: 52 · 2024: 42 · 2023: 46 · 2022: 48 · 2021: 57 · 2020: 25 · 2019: 5
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Funders
- Research Committee, University of Thessaly (5309.17.03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- hypoxia-inducible factor, lipid metabolism, hypoxia, transcriptional regulation, lipid degradation, cancer cells, tumor progression, metabolic disorders, transgenic animal models
- MeSH terms
- Animals, Hypoxia, Cardiovascular Diseases, Humans, Neoplasms, Oxygen, Lipid Metabolism, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.